Back to FDA Applications sponsored by BOEHRINGER INGELHEIM

FDA Drug Application 020393 by BOEHRINGER INGELHEIM

Application Number020393
Application Type New Drug Application
Sponsor ApplicantBOEHRINGER INGELHEIM
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New formulation
Therapeutic Potential Standard
Orphan Code 


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP010/20/1995N       
AP04/1/1998SE1403001   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/20393ltr.pdf 4/1/1998
AP01/27/2000SCM       
AP08/18/1999SCS       
AP05/23/2003SLR5746004   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/20393slr004,20394slr005ltr.pdf 5/30/2003
AP05/23/2003SLR5882004   http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20393slr004,20394slr005_atrovent_lbl.pdf 6/8/2003
AP011/30/2007SLR18600007   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/020393s007,020394s008ltr.pdf 12/3/2007
AP011/30/2007SLR18611007   http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020393s007,020394s008lbl.pdf 12/3/2007
AP02/2/2011SLR27753011   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020393s011ltr.pdf 2/7/2011
AP01/5/2015SCM       
AP05/11/2015SCM       




Back to FDA Applications sponsored by BOEHRINGER INGELHEIM

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.